Advisory Council for the Elimination of Tuberculosis Meeting (ACET), 9925-9926 [2013-03133]

Download as PDF 9925 Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices launched in 2007. As it was designed to provide baseline information and to be repeated every two years, it was conducted again in 2009 and 2011. The survey inquired about patient education and support for breastfeeding throughout the maternity stay as well as staff training and maternity care practices. OMB approval for the 2007 survey included a request to CDC to provide, prior to the fielding of the 2009 iteration, a report to the Office of Management and Budget (OMB) on the results of the 2007 collection. In this report, CDC provided survey results by geographic and demographic characteristics and a summary of activities that resulted from the survey. A summary of mPINC findings was also the anchor of all activities related to the CDC August 2011 Vital Signs activity, marking the first time that CDC decided to highlight improving hospital maternity practices as the CDC-wide public health priority for the month. A major strength of the mPINC survey design is its structure as an ongoing, national census. The 2013 and 2015 mPINC surveys repeat the prior iterations (2007, 2009, and 2011). Ensuring that the methodology, content, and administration of these will match high interest among the respondent population. The estimated burden for the Telephone Screening Interview is five minutes, and the estimated burden for completing the mPINC Survey is 30 minutes. As with the initial surveys, a major goal of the 2013 and 2015 follow-up surveys is to be fully responsive to facilities’ needs for information and technical assistance. CDC will provide direct feedback to respondents in a customized benchmark report of their results and identify and document progress since 2007 on their quality improvement efforts. CDC will use information from the mPINC surveys to identify, document, and share information related to incremental changes in practices and care processes over time at the hospital, state, and national levels. Data will be also used by researchers to better understand the relationships between hospital characteristics, maternity-care practices, state level factors, and breastfeeding initiation and continuation rates. Participation in the survey is voluntary, and responses may be submitted by mail or through a Webbased system. There are no costs to respondents other than their time. those used before maximizes the utility not only of the data to be collected in the upcoming survey, but also that of data already collected; fidelity to the original design allows for analyses of the wide spectrum of changes and factors at the hospital, regional, state, and national levels that affect any given hospital’s practices. The census design does not employ sampling methods. Facilities are identified by using the American Association of Birth Centers (AABC) and the American Hospital Association (AHA) Annual Survey of Hospitals. Facilities that will be invited to participate in the survey include those that participated in previous iterations and those that were invited but did not participate in the previous iterations, as well as those that have become eligible since the most recent mPINC survey. All birth centers and hospitals with ≥1 registered maternity bed will be screened via a brief phone call to assess their eligibility, identify additional locations, and identify the appropriate point of contact. The extremely high response rates to the previous iterations of the mPINC survey (82% in 2007 and 2009, and 83% in 2011) indicate that the methodology is appropriate and also reflects unusually ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) Type of respondent Form name AHA Hospitals with either > 1 birth or > 1 registered maternity bed. Telephone Screening Interview ....... 2,398 1 5/60 200 AABC Birth Centers .......................... mPINC Survey ................................. Telephone Screening Interview ....... mPINC Survey ................................. .......................................................... 1,730 173 95 ........................ 1 1 1 ........................ 30/60 5/60 30/60 ........................ 865 14 48 1,127 Total ........................................... Kimberly S. Lane, Deputy Director, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2013–03194 Filed 2–11–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES tkelley on DSK3SPTVN1PROD with NOTICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting (ACET) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) VerDate Mar<15>2010 16:40 Feb 11, 2013 Jkt 229001 announces the following meeting of the aforementioned committee: Time and Date: 11:00 a.m.–2:30 p.m., March 5, 2013. Place: This meeting is accessible by Web conference. Toll-free +1 (888) 324– 9613, Toll +1 (312) 470–7151; Participant Code: ACET For Participants: URL: https:// www.mymeetings.com/nc/join/ Conference number: PW4516585 Audience passcode: ACET Participants can join the event directly at: https:// www.mymeetings.com/nc/ join.php?i=PW4516585&p=ACET&t=c. Status: Open to the public limited only by web conference. Participation by web conference is limited by the number of ports available (150). PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 Purpose: This council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters to Be Discussed: Agenda items include the following topics: (1) ACET Chair’s report to the Secretary; (2) Roles and responsibilities for Federal Advisory Committees; (3) Recommendations of topics for the June 2013 ACET meeting; and (4) other E:\FR\FM\12FEN1.SGM 12FEN1 9926 Federal Register / Vol. 78, No. 29 / Tuesday, February 12, 2013 / Notices tuberculosis-related issues. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, CDC, 1600 Clifton Road, NE., M/S E–07, Atlanta, Georgia 30333, telephone (404) 639–8317; Email: zkr7@cdc.gov The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). [FR Doc. 2013–03133 Filed 2–11–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review tkelley on DSK3SPTVN1PROD with NOTICES The meeting announced below concerns Medicaid Expansion and Reproductive Health Care for Women, FOA DP 13–002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–5:00 p.m., April 4, 2013 (Closed). Place: Teleconference . Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Medicaid Expansion and Reproductive Health Care for Women, FOA DP 13–002, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and VerDate Mar<15>2010 16:40 Feb 11, 2013 Jkt 229001 Prevention and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2013–03131 Filed 2–11–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Prevalence and Incidence of Inflammatory Bowel Disease, FOA DP 13–001, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–5:00 p.m., April 16, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Prevalence and Incidence of Inflammatory Bowel Disease, FOA DP 13– 001, initial review.’’ Contact Person for More Information: M. Chris Langub, Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, NE., Mailstop F–46, Atlanta, Georgia 30341, Telephone: (770) 488–3585, EEO6@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–03132 Filed 2–11–13; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Cooperative Research Agreements Related to the World Trade Center Health Program (U01) PAR 12– 126, initial review. Correction: The notice was published in the Federal Register on January 30, 2013, Volume 78, Number 20, Page 6329. The place should read as follows: Place: Atlanta Marriott Century Center, 2000 Century Boulevard NE., Atlanta, Georgia 30345–3306, Telephone: (404) 325–0000. Contact Person for More Information: Nina Turner, Ph.D., Scientific Review Officer, CDC, 1095 Willowdale Road, Mailstop G800, Morgantown, West Virginia 26505, Telephone: (304) 285– 5976. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–03134 Filed 2–11–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Cost-Benefit of Incentive-based Smoking Cessation for Pregnant Women, FOA DP 13–003, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–5:00 p.m., April 2, 2013 (Closed). Place: Teleconference . Status: The meeting will be closed to the public in accordance with provisions set E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 78, Number 29 (Tuesday, February 12, 2013)]
[Notices]
[Pages 9925-9926]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03133]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis Meeting 
(ACET)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting of the aforementioned 
committee:
    Time and Date:
    11:00 a.m.-2:30 p.m., March 5, 2013.
    Place: This meeting is accessible by Web conference. Toll-free +1 
(888) 324-9613, Toll +1 (312) 470-7151; Participant Code: ACET
    For Participants: URL: https://www.mymeetings.com/nc/join/
    Conference number: PW4516585
    Audience passcode: ACET
    Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW4516585&p=ACET&t=c.
    Status: Open to the public limited only by web conference. 
Participation by web conference is limited by the number of ports 
available (150).
    Purpose: This council advises and makes recommendations to the 
Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.
    Matters to Be Discussed: Agenda items include the following topics: 
(1) ACET Chair's report to the Secretary; (2) Roles and 
responsibilities for Federal Advisory Committees; (3) Recommendations 
of topics for the June 2013 ACET meeting; and (4) other

[[Page 9926]]

tuberculosis-related issues. Agenda items are subject to change as 
priorities dictate.
    Contact Person for More Information: Margie Scott-Cseh, CDC, 1600 
Clifton Road, NE., M/S E-07, Atlanta, Georgia 30333, telephone (404) 
639-8317; Email: zkr7@cdc.gov
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 2013-03133 Filed 2-11-13; 8:45 am]
BILLING CODE 4163-18-P